Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000591302 | SCV000701873 | likely benign | not specified | 2016-11-03 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000591302 | SCV000711242 | benign | not specified | 2016-12-22 | criteria provided, single submitter | clinical testing | p.Thr698Thr in Exon 12 of USH2A: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue, is not located with in the splice consensus sequence, and has been identified in 0.5% (48/10398) of African chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broad institute.org; dbSNP rs141489104). |
Labcorp Genetics |
RCV000915960 | SCV001061187 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000915960 | SCV001786359 | likely benign | not provided | 2020-12-30 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003451341 | SCV004182459 | benign | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003451340 | SCV004182460 | benign | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000915960 | SCV005263717 | likely benign | not provided | criteria provided, single submitter | not provided |